학술논문
'학술논문'
에서 검색결과 256건 | 목록
1~10
Academic Journal
Cancer Management and Research, Vol 2012, Iss default, Pp 397-411 (2012)
Academic Journal
Winer LK; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Akumuo R; Department of General Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.; Fredette JD; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Deng M; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Hasler JS; Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Greco SH; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; von Mehren M; Division of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Bartholomew AJ; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.; Blazer DG; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.; Gabrielova L; Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic.; Adamkova D; Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic.; Bernard-Bedard E; Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada.; Nessim C; Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada.; Kollár A; Department of Medical Oncology, Inselspital, Bern University Hospital, Univesity of Bern, Bern, Switzerland.; Olariu R; Department of Plastic and Hand Surgery, Inselspital, Bern University Hospital, Freiburgstrasse, Switzerland.; Cencelj-Arnez R; Division of Surgery, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Hompes D; Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.; Ford SJ; Sarcoma Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.; Cardona K; Division of Surgical Oncology, Emory University Hospital, Atlanta, Georgia, USA.; Sato K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.; Iwata S; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.; Farma JM; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Villano AM; Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Schuetze S; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.; Rothe M; American Society of Clinical Oncology, Alexandria, VA.; Mangat PK; American Society of Clinical Oncology, Alexandria, VA.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA.; Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX.; Calfa CJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.; Farrington LC; City of Hope Chicago, Zion, IL.; Livingston MB; Levine Cancer Institute, Atrium Health, Charlotte, NC.; Wentzel K; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA.; Behl D; Sutter Sacramento Medical Center, Sacramento, CA.; Kier Y; Cancer Research Consortium of West Michigan, Grand Rapids, MI.; Marr AS; University of Nebraska Medical Center, Omaha, NE.; von Mehren M; Fox Chase Cancer Center, Philadelphia, PA.; Press JZ; Swedish Cancer Institute, Seattle, WA.; Thota R; Intermountain Healthcare, Murray, UT.; Grantham GN; American Society of Clinical Oncology, Alexandria, VA.; Gregory A; American Society of Clinical Oncology, Alexandria, VA.; Hinshaw DC; American Society of Clinical Oncology, Alexandria, VA.; Halabi S; Duke University Medical Center, Durham, NC.; Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Mühlenberg T; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.; Falkenhorst J; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.; Schulz T; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.; Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany.; Fletcher BS; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.; Teuber A; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.; Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany.; Krzeciesa D; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.; Klooster I; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Lundberg M; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Wilson L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Lategahn J; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.; Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany.; von Mehren M; Department of Hematology and Oncology, Fox Chase Cancer Center, Temple Health System, University, Philadelphia, PA.; Grunewald S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.; Tüns AI; Laboratory of Molecular Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Wardelmann E; Gerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany.; Sicklick JK; Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, CA.; Department of Pharmacology, Moores Cancer Center, University of California San Diego, San Diego, CA.; Brahmi M; Centre Leon Berard, Medical Oncology, Lyon, France.; Serrano C; Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Schildhaus HU; University Hospital Essen, Institute of Pathology, Essen, Germany.; Current affiliation: Discovery Life Sciences Biomarker Services & Institute of Pathology Nodhessen, Kassel, Germany.; Sievers S; Compound Management and Screening Center, Max Planck Institute of Molecular Physiology, Dortmund, Germany.; Treckmann J; University of Duisburg-Essen, Medical School, Department of Visceral and Transplantation Surgery, Essen, Germany.; Heinrich MC; Portland VA Health Care System and OHSU Knight Cancer Institute, Portland, OR.; Raut CP; Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Ou WB; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.; Marino-Enriquez A; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; George S; Dana-Farber Cancer Institute, Medical Oncology, Boston, MA.; Rauh D; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.; Drug Discovery Hub Dortmund (DDHD) am Zentrum für Integrierte Wirkstoffforschung (ZIW), Dortmund, Germany.; Fletcher JA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany.; DKTK partner site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Ninmer EK; Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, VA, USA.; Zhu H; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.; University of Virginia, School of Medicine, Cancer Center, Charlottesville, VA, USA.; Chianese-Bullock KA; Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, VA, USA.; University of Virginia, School of Medicine, Cancer Center, Charlottesville, VA, USA.; von Mehren M; Fox Chase Cancer Center, Philadelphia, PA, USA.; Haas NB; Fox Chase Cancer Center, Philadelphia, PA, USA.; University of Pennsylvania, Philadelphia, PA, USA.; Ross MI; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Dengel LT; Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, VA, USA.; Slingluff CL Jr; Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, VA, USA. cls8h@uvahealth.org.; University of Virginia, School of Medicine, Cancer Center, Charlottesville, VA, USA. cls8h@uvahealth.org.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Schuetze SM; University of Michigan-Ann Arbor, Ann Arbor, MI, United States.; Ballman KV; Mayo Clinic, United States.; Heise R; University of California, San Francisco, New York, NY, United States.; Ganjoo KN; Stanford University, Stanford, CA, United States.; Davis EJ; Vanderbilt University Medical Center, Nashville, TN, United States.; George S; Dana-Farber Cancer Institute, Boston, MA, United States.; Burgess MA; U Pittsburgh, Pittsburgh, PA, United States.; Choy E; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.; Shepard DR; Cleveland Clinic, Cleveland, OH, United States.; Tinoco G; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.; Hirbe A; Washington University in St. Louis, saint louis, United States.; Kelly CM; Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Attia S; Mayo Clinic, Jacksonville, Florida, United States.; Deshpande HA; Yale University.; Schwartz GK; Case Western Reserve University, Cleveland, OH, United States.; Siontis BL; Mayo Clinic, Rochester, MN, United States.; Riedel RF; Duke University Health System, Durham, NC, United States.; von Mehren M; Fox Chase Cancer Center, Philadelphia, PA, United States.; Kozlowski E; Sarcoma Alliance for Research through Collaboration, United States.; Chen HX; National Cancer Institute, Bethesda, MD, United States.; Astbury C; Cleveland Clinic, United States.; Rubin BP; Cleveland Clinic and Lerner Research Institute, Cleveland, OH, United States.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Heinrich MC; Division of Hematology/Oncology, Portland VA Health Care System, Portland, OR, USA.; Department of Medicine, OHSU Knight Cancer Institute, Portland, OR, USA.; Jones RL; Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.; George S; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; von Mehren M; Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA.; Zalcberg JR; Department of Medical Oncology, Monash University School of Public Health and Preventive Medicine, Alfred Health, Melbourne, Victoria, Australia.; Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Korea.; Razak AA; Division of Medical Oncology, Toronto Sarcoma Program, Princess Margaret Cancer Center, Toronto, ON, Canada.; Trent J; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA.; Attia S; Department of Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.; Le Cesne A; Medical Oncology Department, Gustave Roussy, Villejuif, France.; Siontis BL; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.; Goldstein D; Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.; Boye K; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Sanchez C; Department of Hematology-Oncology, Centro de Cáncer, Hospital Clínico Pontificia Universidad Católica de Chile, Santiago, Chile.; Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.; Druta M; Sarcoma Program, Moffitt Cancer Center, Tampa, FL, USA.; Serrano C; Sarcoma Translational Research Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Reichmann W; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Sprott K; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Translational Medicine, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Achour H; Biometrics, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Sherman ML; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Ruiz-Soto R; Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Sebastian.Bauer@uk-essen.de.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany. Sebastian.Bauer@uk-essen.de.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Movva S; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Memorial Sloan Kettering Cancer Center, New York, New York.; Matloob S; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Handorf EA; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Cancer Institute of New Jersey, New Brunswick, New Jersey.; Choy E; Massachusetts General Hospital, Boston, Massachusetts.; Merriam P; Dana-Farber Cancer Institute, Boston, Massachusetts.; Flieder DB; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Cai KQ; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Zhou Y; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Tetzlaff ED; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Pagan C; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Barker E; Dana-Farber Cancer Institute, Boston, Massachusetts.; Veggeberg R; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Zumpano D; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; Rink L; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; von Mehren M; Fox Chase Cancer, Center, Philadelphia, Pennsylvania.; George S; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Heinrich MC; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Corless CL; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Demetri GD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Blanke CD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; von Mehren M; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Joensuu H; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; McGreevey LS; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Chen CJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Van den Abbeele AD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Druker BJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Kiese B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Eisenberg B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Roberts PJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Singer S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Fletcher CDM; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Silberman S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Dimitrijevic S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Fletcher JA; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Gelderblom H; Leiden University Medical Center, Leiden, the Netherlands.; Jones RL; Royal Marsden Hospital and Institute of Cancer Research, London, UK.; Blay JY; Centre Léon Bérard and University Claude Bernard Lyon 1, Lyon, France.; George S; Dana-Farber Cancer Institute, Boston, MA, USA.; von Mehren M; Fox Chase Cancer Center, Philadelphia, PA, USA.; Zalcberg JR; Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia.; Kang YK; Asan Medical Center, University of Ulsan, Seoul, Korea.; Razak AA; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Trent J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Attia S; Mayo Clinic, Jacksonville, FL, USA.; Le Cesne A; Gustave Roussy, Vellejuif, France.; Siontis BL; Mayo Clinic, Rochester, MN, USA.; Goldstein D; Prince of Wales Hospital and Clinical School University of New South Wales, New South Wales, Australia.; Boye K; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Sanchez C; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.; Druta M; Moffit Cancer Center, Tampa, FL, USA.; Serrano C; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Somaiah N; MD Anderson Cancer Center, Houston, TX, USA.; Chi P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Harrow B; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA. Electronic address: brooke.harrow@deciphera.com.; Becker C; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Reichmann W; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Sherman ML; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Ruiz-Soto R; Deciphera Pharmaceuticals, LLC, Waltham, MA, USA.; Heinrich MC; Portland VA Healthcare System and Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Bauer S; Department of Medical Oncology and Sarcoma Center at the West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] von Mehren M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어